Blood Group Typing Market revenue to hit USD 2 Billion by 2033, says Research Nester
February 05, 2024 06:00 ET
|
Research Nester
New York , Feb. 05, 2024 (GLOBE NEWSWIRE) -- The global blood group typing market size is slated to expand at 7% CAGR between 2023 and 2033. The market is poised to garner a revenue of USD 2 billion...
Predicine to Present Four Studies at 2023 ASCO Genitourinary (GU) Symposium Highlighting the Technical and Clinical Utility of Predicine’s Liquid Biopsy Based Assays
February 16, 2023 16:05 ET
|
Predicine
HAYWARD, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Predicine, a global molecular insights company, is committed to advancing genitourinary (GU) cancer detection and treatment decisions through its...
Apollo Reports Final Silver Intercepts from the Calico 2022 Drill Program
February 01, 2023 07:00 ET
|
Apollo Silver Corp.
VANCOUVER, British Columbia, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Apollo Silver Corp. (“Apollo” or the “Company”) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to report further assay results...
Predicine to Introduce PredicineCOMPLETE™, its Genome-Wide Liquid Biopsy Solution, at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
November 10, 2022 21:00 ET
|
Predicine
SILICON VALLEY, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Predicine, a global molecular insights company, announces the introduction of PredicineCOMPLETE™, the organization’s most comprehensive...
Predicine’s Liquid Biopsy Next-Generation Sequencing (NGS) Assay is Granted Breakthrough Device Designation by U.S. Food and Drug Administration
September 20, 2022 09:00 ET
|
Predicine
HAYWARD, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Predicine, Inc., a global molecular insights company committed to advancing precision medicine in oncology and infectious diseases, announced...
Predicine Expands to Europe with the recently launched CE-Marked cfDNA Assay PredicineCARE™ for Genomic Profiling in Blood and Urine
August 09, 2022 08:00 ET
|
Predicine
SILICON VALLEY, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Predicine, Inc., a global molecular insights company, has launched its CE-marked PredicineCARE™ for genomic profiling in blood and urine....
Gold Bull encounters coarse gold in samples at Sandman, improved laboratory assay analysis underway – higher grades expected
June 01, 2021 06:30 ET
|
Gold Bull Resources Corp.
VANCOUVER, British Columbia, June 01, 2021 (GLOBE NEWSWIRE) -- Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company”) is pleased to report re-assay results of RC drill samples from...
REPEAT -- Gold Bull intersects 144.8m at 1.67g/t gold, including 6.1m at 10.75g/t gold in maiden drill hole at Sandman
March 22, 2021 08:00 ET
|
Gold Bull Resources Corp.
VANCOUVER, British Columbia, March 22, 2021 (GLOBE NEWSWIRE) -- Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company”) is pleased to report assay results for the first hole drilled...
Gold Bull intersects 144.8m at 1.67g/t gold, including 6.1m at 10.75g/t gold in maiden drill hole at Sandman
March 22, 2021 02:00 ET
|
Gold Bull Resources Corp.
VANCOUVER, British Columbia, March 21, 2021 (GLOBE NEWSWIRE) -- Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company”) is pleased to report assay results for the first hole drilled...
Precipio Launches COVID-19 Antibody Testing at Point-of-Care
January 28, 2021 09:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that following receipt of an Emergency Use Authorization from the FDA...